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ABSTRACT Concentration is a key parameter in controlling the aggregation of self-assembling oligopeptides. By investigating
the concentration effects, an aggregation mechanism of EAK16-II is proposed. Depending on the critical aggregation
concentration (CAC) of EAK16-II, the oligopeptide aggregates into protoﬁbrils through seeding and/or a nucleation process.
Protoﬁbrils then associate with each other to form ﬁbrils. The CAC was found to be ;0.1 mg/ml by surface tension
measurements. The nanostructures of aggregates were imaged and analyzed by atomic force microscopy. Globular and ﬁbrillar
aggregates were observed, and their dimensions were further quantiﬁed. To ensure that the aggregates were formed in bulk
solution, light scattering (LS) measurements were conducted to monitor the ﬁbril formation with time. The LS proﬁle showed two
different rates of aggregation depending on whether the peptide concentration was above or below the CAC. At high
concentrations, the LS intensity increased strongly at early times. At low concentrations, the LS intensity increased only slightly.
Our study provides information about the nature of the oligopeptide self-assembly, which is important to the understanding of
the ﬁbrillogenesis occurring in conformational diseases and to many biomedical engineering applications.
INTRODUCTION
Self-assembling oligopeptides are a new class of biomate-
rials, which have many potential applications in biomedi-
cal and pharmaceutical areas. Originally found in zoutin,
a reported Z-DNA binding protein in yeast, the self-
assembling oligopeptides are biocompatible and biodegrad-
able (Zhang et al., 1993). These properties make them ideal
as matrices in tissue engineering and carriers in drug delivery
systems (Zhang et al., 1993, 1995; Holmes et al., 2000;
Zhang and Altman, 1999). Playing an active role in cell
adhesion, cell morphologies, and cell functions, matrices
made of self-assembling oligopeptides have been reported to
support mammalian cell attachment in different manners
(Zhang et al., 1995). Self-assembling oligopeptides have
been used as a scaffold for neurite outgrowth and synapse
formation, and do not induce any measurable immune re-
sponse or tissue inﬂammation when introduced into animals
(Holmes et al., 2000).
The self-association of oligopeptides into insoluble
macroscopic membranes could be considered as a model
system for studying insoluble macrostructures, which have
been found in many neurological disorders, such as
Alzheimer’s disease (Zhang et al., 1993, 1994; Altman
et al., 2000; Zhang and Rich, 1997; Zhang and Altman,
1999). The macroscopic membranes or plaques can interfere
with or even prevent cell-to-cell communications, which
results in neurological disorders. One well-known self-
assembling biomolecule is the amyloid b-protein (Ab),
which has been found to be an important factor in the cause
of Alzheimer’s disease (Ghanta et al., 1996). Much research
has been done on amyloid aggregation by studying Ab under
different conditions (Halverson et al., 1990; Fraser et al.,
1991; Fraser et al., 1994; Good and Murphy, 1995; Shen and
Murphy, 1995; Yang et al., 1999; Kowalewski and Holtz-
man, 1999); however, the self-assembly process of Ab is so
complicated that it has not been fully understood. Rather
than looking at the complete Ab molecule (a peptide con-
sisting of 40–42 amino acids), the study of the self-assembly
of simpler oligopeptides may be an alternative. These oli-
gopeptides could be used as model systems that would en-
able the ﬁnding of inhibitors that prevent ﬁbrillogenesis and
possibly, provide therapy to neurological disorders.
To understand the self-assembly mechanism of a given
oligopeptide, it is necessary to study the conditions under
which the oligopeptides aggregate and further develop into
macrostructures. Among many conditions, the amino acid
sequence and the pH are known to affect the aggregation of
peptides (unpublished data) as well as the folding and
function of proteins. In fact, the various biological environ-
ments in the human body are highly pH speciﬁc (i.e., pH 5 in
the mouth; pH 1.5 and pH 7.4 in the stomach and blood,
respectively) (Campbell, 1993). Concentration is another
parameter which is important to the self-assembly of
biomolecules. The concentration dependence of self-assem-
bling oligopeptides is expected to be similar to that of
biosurfactants, which have both hydrophobic and hydro-
philic parts. By analogy with surfactants, a concentration
study may allow one to determine the critical aggregation
concentration (CAC). Similar to micellar systems, it is
expected that the oligopeptides are in the monomer form
below the CAC, while peptide aggregation starts to occur at
and above the CAC. Time is also involved in the aggregation
process. It provides information on the timescale over which
the aggregation takes place. This is important to understand
the kinetics of aggregation.
Submitted August 23, 2002, and accepted for publication February 10,
2003.
Address reprint requests to P. Chen, Fax: 1-519-746-4979; E-mail: p4chen@
cape.uwaterloo.ca.
 2003 by the Biophysical Society
0006-3495/03/07/537/12 $2.00
In our research, we chose EAK16, a typical member of
the self-assembling oligopeptide family, as the ﬁrst step to
understand the self-assembly mechanism. EAK16 contains
three amino acids (Ala, Glu, and Lys) connected into a well-
deﬁned sixteen amino acid long sequence. The hydrophobic
Ala and hydrophilic Glu and Lys are assembled in a regularly
organized sequence, which results in unique amphiphilic
properties. EAK16-II is characterized by two negative and
positive charges alternating in sequence (1111)
(Zhang and Altman, 1999). Its molecular structure is shown
in Fig. 1. EAK16-II molecules spontaneously assemble to
form an insoluble macroscopic membrane upon addition of
salt in aqueous solution (Zhang et al., 1993). Further
investigation led to the proposal that the macroscopic
membrane is formed by the stacking of b-sheets through
ionic complements and hydrophobic interactions (Zhang
et al., 1994; Altman et al., 2000). The b-sheet structure is
stable at temperatures as high as 908C and over a wide pH
range, from pH 1.5 to pH 11 (Zhang and Altman, 1999).
In this paper, we characterize how concentration affects
EAK16-II aggregation. Three techniques have been used.
Surface tension measurements are commonly used to in-
vestigate the solution properties of molecules with an
amphiphilic structure. One of the methods to determine
surface tension is axisymmetric drop shape analysis-proﬁle
(ADSA-P) (Adamson and Gast, 1997; Lahati et al., 1996),
which is a powerful and reliable technique to generate surface
information. ByADSA-P, the surface tension obtained can be
plotted against the bulk concentration, which reﬂects the
aggregation status and possibly, the CAC of EAK16-II.
Atomic force microscopy (AFM) is employed to visualize
the nanostructures of EAK16-II aggregates. From AFM,
high resolution images can be acquired. This images pro-
vide structural details about the aggregates. These images are
further analyzed to construct the adsorption isotherm of
EAK16-II on mica surface and also to quantify the dimen-
sions of the nanostructures. However, both surface tension
measurements and AFM observe surface properties only. To
complement the AFM and surface tension data, light
scattering (LS) measurements are employed to gain in-
formation about the aggregation in bulk solution. Based on
the proportionality relationship existing between the LS
intensity and the particle sizes, the LS intensity reﬂects the
increase in the aggregate size once aggregates form in
solution. Furthermore, information about the kinetics of the
self-assembly could be obtained by monitoring the LS inten-
sity as a function of time. Through these three approaches,
a mechanism can be proposed to describe the aggregation
process of EAK16-II.
MATERIALS AND METHODS
Peptide solution preparation
The peptide, EAK16-II with the sequence AcN-AEAEAKAKAEAEA-
KAK-CNH2 and a molecular weight of 1656.79, was purchased from
Research Genetics (Huntsville, AL). For AFM and surface tension
measurements, the peptide solutions were prepared by dissolving in pure
water (Millipore, 18.2V) at concentrations ranging from 0.005 mg/ml to 5.0
mg/ml. Very low EAK16-II concentrations (\0.05 mg/ml) were obtained by
diluting the stock solution (0.05 mg/ml) using a 10–100ml micropipette. The
measurements were performed 1 day after the sample preparation. For the
LS measurements, the EAK16-II solutions with concentrations varying from
0.1 mg/ml to 0.2 mg/ml were prepared by diluting from 0.3 mg/ml stock
solution. The solutions with concentrations ranging from 0.013 mg/ml to
0.05 mg/ml were diluted from 0.08 mg/ml solution. The samples were
divided into sets of four concentrations each for experimental convenience.
Each set of samples (four concentrations) required 30 min to prepare. The
solutions were stored in 20-ml vials after each test. The time-dependent LS
experiments were performed less than 30 min after the solution was
prepared. All experiments were conducted at room temperature.
Surface tension measurement
Axisymmetric drop shape analysis-proﬁle was used to study the dynamic
surface tension of EAK16-II solutions. For a dynamic process, the surface
tension varies as a function of time. For a typical surfactant, the surface
tension decreases with time before reaching an equilibrium value. The
experimental setup has been described in an earlier publication (Chen et al.,
1996). The EAK16-II solution was released at a speed of 0.04 ml/s for 5 s
using a 1-ml motor-driven syringe to form a pendent drop at the tip of the
syringe needle (inner diameter, 0.92 mm). The surface tension was measured
for 1 h for every sample. The experimental sample chamber was saturated
with pure water vapor to keep a consistent humid environment. For each run,
images were acquired at 0.5-s intervals for the ﬁrst 60 s, then at 20-s intervals
for the remaining time. Images were magniﬁed by an optical microscope,
and then captured by a CCD camera before being transferred to the
computer. All images were digitized and analyzed to extract the drop proﬁle.
The surface tension was obtained as a ﬁtting parameter when the
experimental drop proﬁle was ﬁtted to the theoretical curve governed by
the Laplace equation of capillarity (Rotenberg et al., 1983). The standard
deviation of all results is less than 0.2 mJ/m2.
Atomic force microscopy
The nanostructure of the aggregates was investigated by an atomic force
microscope (PicoScan, Molecular Imaging, Phoenix, AZ). To prepare the
AFM samples, 50 ml EAK16-II solution was put on a mica surface, which
was afﬁxed to a multiple use AFM sample plate. The sample was left for 30
min to let the peptide adhere to the mica surface. It was, then, washed twice
with 50 ml water. The sample plate was covered by a petri dish to avoid any
possible contamination and was left for 1–2 h to dry out completely. Silicon
crystal tips (type NCL-16, Molecular Imaging) with a spring constant of 31–
FIGURE 1 3D optimized molecular structure of EAK16-II. The amino
acid sequence is AEAEAKAKAEAEAKAK. Two alternating positive (1)
and negative () charges correspond to the glutamic acid (E) and lysine (K)
residues, respectively. The upper side is hydrophobic because of the alanine
(A) residues; the lower side is hydrophilic due to the glutamic acid and lysine
residues. The length of the backbone is around 6.5 nm while the width ranges
from 0.3 to 0.7 nm (3D optimized image from ACD/3D freeware, Toronto,
ON, Canada).
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71 N/m and a radius of curvature of 10 nm were used for AFM tapping mode
(acoustic mode) imaging. The AFM tip resonance frequency for imaging
was between 160 and 180 kHz. Images were scanned and collected at 63 6
mm2, 3 3 3 mm2, and 1.2 3 1.2 mm2 scales for each sample. To show the
details of the nanostructure, only the images at the 1.23 1.2 mm2 scale were
given in the Results section. Images at the 3 3 3 mm2 scale were used for
surface coverage analysis while the dimensions of the nanostructures were
measured from those obtained at the 1.2 3 1.2 mm2 scale.
To obtain the surface coverage of the EAK16-II aggregates, an image
analysis program (Scion Image, Scion corporation, Frederick, MD) was
used. A relatively ﬂat surface was obtained from the AFM images collected
at the scale of 3 3 3 mm2. For each topographical image, a reasonable
threshold was obtained by comparing the threshold image with the original
image to preserve most aggregate features from the background. By ana-
lyzing these images, the surface area covered by the EAK16-II aggregates
was obtained. Since the images only represent a fraction of the whole sample
surface, and the ﬁbrils may not be evenly distributed on the mica surface, the
surface coverage can be considered as the ﬁbril density within the ﬁbril
networks.
It has been found that the tip size of a cantilever will affect the
determination of the real size of objects probed by AFM (Forbes et al., 2001;
Vesenka et al., 1992; Markiewicz and Goh, 1994). The height measured by
our AFM is relatively accurate as calibrated with a lipid bilayer (egg
phosphatidylcholine), but the width is a convolution of the actual size of the
objects and that of the tip; That is, the true width is related to the tip size and
the shape of the object. To correct the distortion induced by the ﬁnite tip size,
Vesenka et al. (1992) derived an equation to predict the diameter by
assuming the particle under observation to be spherical. The observed width,
W, is approximately equal to 4
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
RcRm
p
, where Rm and Rc are the radius of
the particles measured by AFM and the radius of curvature of the tip,
respectively.
This equation does not apply to our system because the EAK16-II ﬁbrils
are not spherical. In fact, the height of EAK16-II ﬁbrils is 20 times smaller
than their width. To correct the ﬁbril width measured by AFM, a new
equation has been derived for a sheetlike structure with a height H and
a widthW* shown in Fig. 2. The actual ﬁbril widthW* can be calculated by
the equation, W ¼ W  2 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃHð2Rc  HÞ
p
, where W is the observed ﬁbril
width from AFM. For EAK16-II ﬁbrils (H ¼ 0.5–5 nm) and silicone crys-
tal tips (Rc ¼ 10 nm) used in the AFM work, the actual ﬁbril width W* is
;15–30% less than the observed ﬁbril width W. All ﬁbril widths discussed
in this article have been corrected by this method.
Light scattering
The light scattering experiments were carried out on a steady state
ﬂuorescence system (type LS-100, Photon Technology International (PTI),
London, ON, Canada) with a pulsed xenon ﬂash lamp as the light source.
The light scattering peak arose from the interaction of the EAK16-II
aggregates and the incoming excitation light. The samples were irradiated at
314 nm, and the scattered light was monitored from 295 nm to 330 nm. The
excitation and emission slit widths of the monochromators, which control
the amount of light coming in and out of the sample chamber, were set at ½
and 2 turns to yield a spectral resolution of 1 nm and 4 nm, respectively. The
EAK16-II solution was transferred from the vial into a square cell by a glass
pipette for each test. The lamp intensity of the ﬂuorometer was monitored for
each sample. Each scattering intensity was divided by the lamp intensity to
account for eventual lamp ﬂuctuations. All samples were tested in 1-h
intervals initially, and then once a day or once every two days over a period
of 3 weeks. The experimental LS data proﬁles were ﬁtted with two
exponential functions. The parameters of these functions were obtained by
optimizing the ﬁts with the Marquardt-Levenberg algorithm (Press et al.,
1992).
The LS intensity is expected to increase with the dimension of particles
present in solutions. The sensitivity of LS to particle size was conﬁrmed by
monitoring the LS intensity of latex particles with varying diameters. Latex
particles (polystyrene carboxylate-modiﬁed beads) with diameters of 0.4 mm
and 0.9 mmwere purchased from Aldrich (Oakville, ON, Canada). Solutions
of 0.4 mm and 0.9 mm diameter latex particles were prepared in pure water
(Milli-Q, 18.6V) with concentration ranging from 0.002 mg/ml to 0.5 mg/
ml. The LS signal was monitored as a function of concentration for both
latex particles. For a given concentration in mg/ml, the solution with larger
particles always gives the larger LS intensity. Thus, the LS data obtained
with the PTI spectroﬂuorometer yields qualitative information about the size
of particles present in solution.
RESULTS
Surface tension measurements
The dynamic surface tension is plotted as a function of time
for each concentration in Fig. 3. At the extremely low
concentrations of EAK16-II (0.005 and 0.01 mg/ml), the
surface tension does not change with time; the surface
tension value is 72.6 mJ/m2, which is similar to the surface
tension of pure water at 21.58C (72.75 mJ/m2) (Adamson and
Gast, 1997). At high concentrations of EAK16-II ([0.1 mg/
ml), the surface tension decreases exponentially with time;
the surface tension drops fast at early times (0–200 s), then
slowly approaches an equilibrium. For the concentrations
between 0.01 mg/ml and 0.1 mg/ml, the dynamic surface
tension proﬁles exhibit an induction period followed by an
exponential drop.
To obtain the equilibrium surface tension from the
dynamic surface tension data, three methods have been em-
ployed. The ﬁrst one is the ‘‘end points’’ or ‘‘last mea-
surements’’ method (Chen et al., 1996). The equilibrium
surface tension is calculated by averaging a certain number
of data points collected at the end of each run (10 points were
FIGURE 2 A schematic diagram for derivation of the equation to correct
the ﬁbril width. The wide dotted line represents the directly observed image
proﬁle from AFMwith a width ofW.W* is the actual width of the ﬁbril. The
actual ﬁbril width can be derived as W* ¼ W  2X, where
X ¼ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃHð2Rc  HÞ
p
. H and Rc are the ﬁbril height and the radius of curva-
ture of the AFM probe tip, respectively. For EAK16-II ﬁbrils and sili-
cone crystal tips (Rc ¼ 10 nm) used in the work, the actual width, W*, is
15%–30% less than the observed width, W.
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used in this study). The second method is referred to as the
‘‘slope method’’ (Chen et al., 1996; Cabrerizo-Vilchez et al.,
1995). For each concentration, the dynamic surface tension
data are simply ﬁtted by a logarithmic function. The ﬁts
yielded R-square values which are above 0.987 for all
surface tension proﬁles. The derivative of the ﬁtted function
gives the instantaneous slope for each experimental point
on the curve. Among the minimum slopes obtained for each
concentration, the largest value, Smax, is identiﬁed and
chosen as the cutoff value for all concentrations. For each
concentration, the surface tension is determined at the point
having a slope equal to Smax. This surface tension is regarded
as the equilibrium surface tension of the solution. Smax has
been found to be 0.0012 mJ/m2s in this study. The third
method to determine an equilibrium surface tension is the
‘‘extrapolation’’ method (Cabrerizo-Vilchez et al., 1995).
For each concentration, the surface tension is plotted versus
1/t0.5.The equilibrium surface tension is estimated by a linear
extrapolation of 1/t0.5 to the y axis. This plot is based on the
assumption that the surface adsorption process occurs
according to a diffusion-controlled mechanism (Cabrerizo-
Vilchez et al., 1995; Makievski et al., 1997). Fig. 4 shows the
surface tension versus 1/t0.5 for all EAK16-II concentrations.
A portion of the data (1/t0.5\0.05) is ﬁtted to a straight line
using linear regression, and the intercept at the y axis (i.e.,
t ¼ ‘) is an estimate of the equilibrium surface tension.
The equilibrium surface tensions obtained by the extrap-
olation method were plotted with the concentration of
EAK16-II in Fig. 5. The proﬁle yields an equilibrium surface
tension around 72.4 6 0.17 mJ/m2 at very low EAK16-II
concentrations. This value is close to the pure water surface
tension. When the concentration increases, the surface
tension drops dramatically down to a minimum of 56.0 6
0.14 mJ/m2 for an EAK16-II concentration of 0.16 mg/ml.
Then the surface tension increases slightly back to 58.9 6
0.12 mJ/m2 at high concentrations. The small dip of the
curve is due to a minute amount of impurities present in the
peptide. It has been reported that depending on their surface
activity, impurities may cause either a minimum or a higher
break point in the surface tension versus peptide concentra-
tion plot (Clint, 1992). The equilibrium surface tension
generated from the slope and the end points methods give
similar proﬁles (data not shown) to that of the extrapolation
method. The concentration of 0.1 mg/ml (6.04 3 105 M)
before the small dip may be regarded as the critical
aggregation concentration of EAK16-II.
For surface active biomolecules, an induction time usually
occurs in dynamic surface tension measurements. The sur-
FIGURE 3 Dynamic surface tension of EAK16-II solutions. The
concentrations are ranging from 0.005 to 4.0 mg/ml. The errors of all data
points are within a standard deviation of 60.3 mJ/m2.
FIGURE 4 Surface tension versus 1/t0.5 for different concentrations of
EAK16-II (0.005–4.0 mg/ml); 1/t0.5 # 0.05s0.5. The errors of all data
points are within a standard deviation of 60.3 mJ/m2. The equilibrium
surface tension was estimated by a linear extrapolation to the y axis.
FIGURE 5 Relationship between the equilibrium surface tension and
concentration of EAK16-II in water solutions. When the concentration
increases, the surface tension drops dramatically down to a minimum value,
then it increases slightly back to a plateau. The critical aggregation
concentration is found to be around 0.1 mg/ml. All data errors are within the
range of 60.18 mJ/m2.
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face tension changes signiﬁcantly, say 5%, only after this
induction period. This is because a certain number of
molecules are needed to adsorb at the surface to affect the
surface tension. The induction time is also related to the size
and the amphiphilicity of the particles in solution (see the
Discussion section). Fig. 3 shows that EAK16-II, a surface
active oligopeptide, has an induction time when the con-
centration is low enough. The induction time, at which the
surface tension decreased by 5%, was plotted as a function of
concentration in Fig. 6. At the concentration of 0.005 mg/ml,
the induction time was too large to be recorded during the
experimental period. As the concentration increases, the in-
duction time decreases. No induction time could be observed
for EAK16-II concentrations larger than 0.1 mg/ml, which
may imply that 0.1 mg/ml represents a critical concentration
for the aggregation process.
AFM images of aggregate nanostructures
The AFM images with a scale of 1.2 3 1.2 mm2 (Fig. 7)
show the dried EAK16-II aggregates. Fibrils (Fig. 7, A–C)
are found in solutions with 0.1, 0.2, and 0.5 mg/ml con-
centrations while isolated ﬁlaments (Fig. 7 D) are found in
the solution with a 0.05 mg/ml concentration. The globular
aggregates, observed at all concentrations, are randomly
dispersed in the 0.05 mg/ml solution, while they seem to line
up and form into elongated ﬁbrils at the higher concen-
trations (0.1, 0.2, and 0.5 mg/ml). The number of observed
nanostructures (i.e., ﬁbrils, ﬁlaments, and globular aggre-
gates) reduces when the concentration is below 0.1 mg/ml. In
addition, the ﬁbril width changes with the concentration as
well. Table 1 lists the size of nanostructures of EAK16-II
observed by AFM. The ﬁbril width decreases from 73.5 6
8.7 nm at a concentration of 0.5 mg/ml to 34.1 6 6.8 nm at
0.05 mg/ml. Similarly, the ﬁbril height also decreases with
concentration from 3.72 6 0.59 nm to 0.41 6 0.09 nm.
However, the diameter of the globular aggregates decreases
as the concentration increases; the height of the globular
aggregates is around 1 nm. The diameter and the height of
the globular aggregates are not available at concentrations
above 0.1 mg/ml since no individual globular aggregate
could be observed.
The density of ﬁbril networks and ﬁbril width are plotted
as a function of EAK16-II concentration in Fig. 8. The ﬁbril
network density shows a sharp increase around the con-
centration of 0.1 mg/ml, but the ﬁbril width does not.
However, the larger error associated with the ﬁbril width for
the 0.1 mg/ml sample may imply a transition where indi-
vidual aggregates associate into a ﬁbril network. It is worth
noting that all AFM images were taken in air-dried con-
dition. During the dehydration process, the peptide concen-
tration increases and more aggregates are expected to form.
Light scattering
Light scattering intensity is proportional to the size of the
particles present in solution. The scattering intensity of the
EAK16-II solutions is plotted as a function of time in Fig. 9
A. From this plot, the proﬁles can be separated into two
groups depending on the EAK16-II concentrations. In the
high concentration group (0.08–0.2 mg/ml), the LS intensity
increases sharply with time within the ﬁrst 6 h, then slowly
approaches a plateau after 160 h. In the low concentration
group (0.013–0.05 mg/ml), the LS intensity does not change
signiﬁcantly over the initial time period, although it increases
slightly after 200 h. The difference in behavior can be clearly
seen in Fig. 9 B. When the concentration is below the CAC,
the LS intensity seems to remain the same at the early times.
On the other hand, a sharp increase occurs when the con-
centration reaches or is above the CAC.
Further evidence is shown in Fig. 9 C by analyzing the rate
of intensity change at the early times. LS data points, over
the ﬁrst 6 h, were ﬁtted to a straight line and their slopes were
plotted as a function of concentration. The value of the slope
changes drastically from 0.17 to 1.45 around 0.08 mg/ml
concentration, which indicates the difference of the aggre-
gation behavior according to the CAC. Fig. 9 D shows that
the LS intensity increases after 5 h when the concentration is
above 0.08 mg/ml, which is close to the CAC determined
earlier (0.1 mg/ml). This experiment demonstrates that
EAK16-II aggregates in bulk solutions with time, and pro-
vides information about the timescale over which the aggre-
gation process occurs.
In Fig. 10, the LS data were normalized by dividing the
scattering intensity by the EAK16-II concentration. Since
little change in LS intensity was observed at low EAK16-II
concentrations, only the data with an EAK16-II concentra-
tion at and larger than 0.08 mg/ml are presented in Fig. 10.
FIGURE 6 Induction time with selected concentrations of EAK16-II. The
induction time is observed as a period before the surface tension starts to
drop in dynamic surface tension measurements. It exists in most bio-
molecular systems. The induction time is close to zero after the con-
centration of 0.05 mg/ml. The data errors range from 61.5 to 6100 s.
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All data were normalized by concentration. They illustrate
that the increase in LS with time is bimodal, being rapid at
early times and slower at later times. This effect appears to be
induced by the shear which occurs as the peptide solution is
forced through the Pasteur pipette into the cell. Pipetting the
solutions once per hour or day results in different rates of
aggregation leading to the bimodal behavior shown in Fig.
10. Consequently, the scattering proﬁles were ﬁtted with two
exponentials to generate a kinetic model of the aggregation
process. The shear-induced association of EAK16-II is not
an isolated case since a similar effect has been reported for
other proteins (Lougheed et al., 1980).
DISCUSSION
Concentration effect on aggregation of EAK16-II
Concentration is a key parameter for characterizing self-
assembly systems. Micellization, a well-known self-asso-
FIGURE 7 AFM images of EAK16-II on mica with different concentrations: (A) 0.5 mg/ml; (B) 0.2 mg/ml; (C) 0.1 mg/ml; (D) 0.05 mg/ml. The size and the
density of ﬁbrils reduce as the concentration decreases. The ﬁbril width of each concentration is 73.56 8.67, 53.96 5.87, 46.86 14.2, and 34.16 6.81 nm in
A, B, C, andD, respectively. Two types of nanostructures, globular aggregates and ﬁlaments, are found at the concentration of 0.05 mg/ml. They are considered
as protoﬁbrils which can further aggregate into ﬁbrils. Arrows indicate the globular aggregates within the ﬁbrils or isolated on the surface. The AFM images
support our proposed aggregation model of EAK16-II.
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ciation process, occurs only when the concentration of
surfactants is larger than the critical micelle concentration
(CMC). By analogy, biomaterials like proteins and self-
assembling oligopeptides may have a critical aggregation
concentration based on their amphiphilic structures. These
amphiphilic biomolecules may aggregate once the concen-
tration is above the CAC.
The EAK16-II molecule, shown in Fig. 1, contains one
hydrophobic side with alanine residues and one hydrophilic
side with glutamic acid and lysine residues. It forms stable
b-sheets spontaneously in aqueous solution mainly through
hydrogen bonding; both the electrostatic forces of the
charged residues and the hydrophobic interactions of the
alanines contribute to further aggregation (Zhang et al.,
1993, 1994; Zhang and Altman, 1999; Altman et al., 2000).
This unique amphiphilic structure of EAK16-II is quite
different from that of a normal surfactant, which contains
a hydrophobic tail and a hydrophilic head. This is certainly
the reason why EAK16-II aggregates into ﬁbrils rather than
forming micelles in solution.
Surface tension measurements lead to the conclusion that
EAK16-II has a CAC around 0.1 mg/ml (6.04 3 105 M).
Although this value is much lower than the CMC of most
commercial surfactants (;103–102 M) (Reif et al., 2001;
Myers, 1992), it compares well with the CMC value reported
for other biosurfactants, which range from 0.001–2 mg/ml
(Mulligan and Gibbs, 1993). For example, both bovine
serum albumin (BSA) and human serum albumin (HSA)
have been found to have a CAC value around 0.05 mg/ml
(;7 3 107 M) (Chen et al., 1996; Makievski et al., 1998;
Fainerman et al., 1998). Interestingly, Alzheimer’s Ab,
another self-assembling polypeptide, also has a CAC of
;2.5 3 105 M (Soreghan et al., 1994), although a later
report shows a CAC of Ab around 1.0 3 105 M at low pH
(Lomakin et al., 1996). Therefore, it is possible to have
a CAC in the range of 105 M for oligopeptides.
The aggregation of EAK16-II is conﬁrmed when
aggregates are visualized by AFM on a mica surface. The
AFM images show three types of nanostructures, which are
the globular aggregates, the ﬁbrils, and the ﬁlaments. Fibrils
are found when the concentration is above 0.1 mg/ml (Fig. 7,
A–C). At a concentration of 0.05 mg/ml, isolated globular
aggregates and ﬁlaments are observed (Fig. 7 D). The
existence of aggregates at this concentration appears to be
contradictory to the micellization theory. However, two
reasons can account for this: The ﬁrst is the dehydration
process. Since the AFM samples are prepared by drying the
solutions on the mica surface, the bulk concentration will
increase signiﬁcantly and may exceed the CAC near the end
of the drying process, which induces the association. Second,
the impurities in the solution may function as seeds, which
can initiate the nucleation process for further aggregation
(see below).
The LS experiments also show that EAK16-II aggregates
at low concentrations (Fig. 9 A). The LS intensity of low
concentration samples (0.03 and 0.05 mg/ml) increases
slightly with time. After 150 h (;6 days), the LS signal
becomes signiﬁcantly higher than the initial value. This is
evidence that aggregation occurs over time at concentrations
below the estimated CAC of 0.1 mg/ml.
Although both AFM images and LS data show that
aggregation of EAK16-II happens at all concentrations, the
aggregation rate depends strongly on the CAC. Fig. 9 C
shows that the rate of LS intensity change, which can be
TABLE 1 The dimensions of EAK16-II nanostructures on mica
Concentration of
Fibril structure Globular structure
EAK16-I (mg/ml) Width (nm) Height (nm) Diameter (nm) Height (nm)
0.05 34.1 6 6.81 0.41 6 0.09 64.3 6 11.7 0.97 6 0.22
0.08 38.1 6 5.31 0.88 6 0.11 39.6 6 7.90 1.10 6 0.33
0.1 46.8 6 14.2 1.63 6 0.29 37.2 6 7.92 0.98 6 0.18
0.2 53.9 6 5.87 1.61 6 0.18 — —
0.5 73.5 6 8.67 3.72 6 0.59 — —
At low concentrations (\0.1 mg/ml), the ﬁbril structures are thin ﬁlaments; at high concentrations ($0.1 mg/ml), the ﬁbrils are composed of globular
aggregates and ﬁlaments based on the proposed model. All errors are within the 95% conﬁdence level. Data were corrected for the tip and shape
convolutions.
FIGURE 8 The density of ﬁbril networks of EAK16-II on mica and the
width of EAK16-II ﬁbrils versus concentrations. The value of ﬁbril density
increases sharply around 0.1 mg/ml (CAC), but the ﬁbril width increases
moderately with concentrations. The large error range of ﬁbril width at 0.1
mg/ml concentration may imply a nucleation process upon the CAC.
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related to the aggregation rate, is very different for the
concentration below and above the CAC. Fig. 9 D indicates
that EAK16-II aggregates much faster at concentrations
above the CAC. The two extreme aggregation rates may
indicate that EAK16-II associates via two different pathways.
Concentration affects both the size and shape of the
nanostructures of EAK16-II. By AFM, three types of
nanostructures were observed. They are the globular ag-
gregates, the ﬁlaments and the ﬁbrils shown in Fig. 7. When
the concentration is below the CAC, both globular aggregates
and thin ﬁlaments exist (Fig. 7 D). The height and width of
the ﬁlaments are ;0.4 nm and 35 nm, respectively, whereas
the height and diameter of the globular aggregates are twice
as large (see Table 1). The size of the nanostructures can be
related to that of one EAK16-II molecule. According to the
structure presented in Fig. 1, the backbone stretches over 6.5
nm and the width ranges from 0.3 to 0.7 nm (estimated by
ACD/3D freeware). Comparing the height of EAK16-II
aggregates with that of one EAK16-II molecule, the ﬁlaments
are monolayers of b-sheets, but the globular aggregates are
made of at least 2 layers of b-sheets.
At the concentration above the CAC, EAK16-II forms
ﬁbrils. These ﬁbrils are made of many globular aggregates
(protoﬁbrils) lining up and stacking together (Fig. 7 A). The
dimensions of the ﬁbrils are ;70 nm in width and 3.7 nm in
height, which are quite different from the ﬁlaments observed
at low concentrations. However, it is very interesting that the
diameter of the globular aggregates at a concentration of 0.05
mg/ml is comparable to the width of the ﬁbrils at 0.5 mg/ml,
although those ﬁbrils are 3.5 3 taller than the globular
aggregates. From the images, no ﬁlaments are observed at
high concentrations ($0.1 mg/ml).
FIGURE 9 (A) Light scattering of EAK16-II solutions with time in different concentrations from 0.013 to 0.2 mg/ml. The data are separated into two groups
according to EAK16-II concentration. In the high concentration group (0.08–0.2 mg/ml), the LS intensity increases dramatically with time within the ﬁrst 10 h.
In the low concentration group (0.013–0.05 mg/ml), the LS intensity does not change much with time. (B) The initial difference of LS intensity upon whether
the concentration is above and below the CAC. Above the CAC (full circle), the LS intensity increases fast within the ﬁrst 6 h. Below the CAC (star), the LS
intensity does not change with time. (C) The rate of LS intensity change over the ﬁrst 6 h (initial slope obtained from Fig. 9 A) as a function of concentration.
[EAK] represents the concentration of EAK16-II. The value jumps dramatically from 0.17 to 1.45 around the CAC, which shows two distinguishable groups of
data. (D) The intensity of light scattering plotted with concentrations at different timescales (d 0.75 h; n 4.75 h;m 109 h). The LS intensity increases after 5 h
when the concentration is above 0.08 mg/ml, which is close to the CAC.
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Both ﬁbrils and individual small globular aggregates are
found at concentrations around the CAC (Fig. 7 C). The
globular aggregates at this concentration (;0.1 mg/ml) are
around 1 nm in height and 35 nm in diameter, which is half the
diameter at 0.05 mg/ml. Table 1 also shows that the diameter
of globular aggregates decreases to the smallest value at 0.1
mg/ml. Therefore, within the concentration range where
isolated globular aggregates can be observed, a minimum
diameter exists at the concentration close to the CAC.
The observation of the smallest diameter of the globular
aggregates at 0.1 mg/ml concentration could be rationalized
by a nucleation process, in which the size of the aggregates
will depend on the number of nuclei formed. At the low
concentration regime (0.05 mg/ml), few nuclei are formed
for EAK16-II molecules to associate leading to the formation
of fewer but larger globular aggregates. When the concen-
tration reaches the CAC, many nuclei appear immediately,
which generates more but smaller globular aggregates as
seen in Fig. 7 C. The formation of ﬁbrils by other self-
assembling molecules (i.e., Ab) has also been described in
terms of a similar nucleation process (Lomakin et al., 1996).
The nuclei formation is expected to depend on concentra-
tion. At concentrations above the CAC, nuclei are generated
by the self-association of EAK16-II molecules. Below the
CAC, impurities in solution may function as seeds (or nuclei)
for the nucleation process. The presence of impurities is
conﬁrmed by the small depression observed by the surface
tension measurements and shown in Fig. 5. The minute
amount of impurities in solution allow EAK16-II molecules
to self-assemble at concentrations below the CAC, which
agrees with the AFM and LS results.
The aggregation of EAK 16 II behaves differently from the
normal surfactant aggregation at concentrations above the
CAC because the typical micellization theory cannot explain
the increase in aggregate size as a function of concentration.
Above the CMC, an increase of the surfactant concentration
leads to an increase of the micelle concentration, not its size
and shape, which only depend on the packing parameter of the
surfactants (Clint, 1992). Similar results have been reported
for the formation of Ab ﬁbrils, where an independent
relationship has been established between the ﬁbril width
andAb concentration above the CMC (Lomakin et al., 1996).
Above the CAC, however, an increase of the EAK16-II
concentration results in the formation of wider and higher
ﬁbrils (Fig. 7A and Table 1). This shows the unique properties
of EAK16-II molecules. Different from surfactants, EAK16-
II forms an open structure of aggregates as opposed to an
enclosed micelle. Once the nuclei of the aggregates are
formed, they keep growing via addition of EAK16-II
monomers leading to a continuous increase in the size of
protoﬁbrils and ﬁbrils with concentration.
Proposed mechanism for self-assembly
To study the mechanism of self-assembly, Zhang and
Altman (1999) hypothesized a simple model to describe
the aggregation process of self-assembling oligopeptides.
Initially, the individual peptides arrange themselves into b-
sheets; then the b-sheets aggregate into ﬁlaments and further
into membranes. However, no direct evidence supports this
proposed model.
Based on our results, an aggregation model of EAK16-II
can be proposed. EAK16-II molecules aggregate to form
ﬁbrils in two stages. First, EAK16-II monomers self-asso-
ciate into protoﬁbrils via a nucleation and/or seeding process
depending on the solution concentration. Below the CAC,
the nuclei are formed only from the seeds (impurities)
present in minute amounts in the solution; above the CAC,
EAK16-II self-assembles to form nuclei, which initiate
further the aggregation of the protoﬁbrils. The protoﬁbrils
can adopt two different nanostructures, i.e., the globular
aggregates and the ﬁlaments. Both structures are composed
of b-sheets, which are held together mainly by hydrogen
bonding. The second step involves the interaction of the
protoﬁbrils with each other to form ﬁbrils. One hypothetical
pathway for ﬁbril formation would have globular aggregates
lining up along the ﬁlaments. At this stage of our study, it is
still unclear why EAK16-II forms either globular aggregates
or ﬁlaments. Certainly, pH and amino acid sequence will
affect the ability of EAK16 to form either globular ag-
gregates or ﬁlaments (unpublished data).
The height of the aggregates reported in Table 1 provides
some information about the association of protoﬁbrils into
ﬁbrils. In the 0.1-mg/ml solution, the ﬁbril height was
observed to be ;1.6 nm. This value matches the sum of the
heights of one globular aggregate and one ﬁlament (1 nm and
0.4 nm, respectively), which supports the assumption that
the globular aggregates line up along the ﬁlaments. It also
indicates that the ﬁbril contains three layers of b-sheets since
one b-sheet layer is;0.5 nm in height. However, at 0.5-mg/
ml concentration, the ﬁbril height increases to ;3.7 nm,
FIGURE 10 Light scattering corrected by bulk EAK16-II concentration
versus time. EAK16-II concentrations range from 0.08 to 0.2 mg/ml. The
data were ﬁtted to a bimodal kinetic model of aggregation of EAK16-II
(solid line). The data was normalized by EAK16-II concentration ([EAK]).
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which is 7 times the height of a b-sheet monolayer. This
implies that the globular aggregates can possibly stack one
on top of another to form higher ﬁbrils at high concen-
trations.
Lomakin et al. (1996, 1997) proposed a model to describe
the aggregation mechanism of Ab in a similar self-assembly
system. In their model, the ﬁbrillogenesis starts with the
presence of nuclei in solution, which are generated by either
seeding or micellization depending upon the concentrations
of Ab. The nuclei provide a core for Ab molecules to re-
arrange themselves into ﬁbrils. The ﬁbril elongation occurs
by irreversible binding of Ab monomers to the ﬁbril ends.
The derivation of association kinetics is based on whether the
bulk concentration of Ab is above or below a critical
concentration (CMC).
The Lomakin et al. model was supported by LS measure-
ments. Their data show two different types of LS intensity
versus time proﬁles depending on whether the Ab concen-
tration is above or below the CMC. Above the CMC, all LS
intensity proﬁles can be normalized and fall on a master
curve. Below the CMC, the LS intensity increases with time
at a rate that decreases with concentration. This behavior
observed for Ab is very similar to that of EAK16-II reported
in Fig. 10. The similarities exhibited by these two association
processes bear the promise that simple oligopeptides like
EAK16-II can be used as a model system to study how
proteins be responsible for neurological disorders (e.g.,
Alzheimer’s disease) self-assemble.
Kinetics of aggregation
Based on the time-dependent light scattering experiments,
the LS data shown in Fig. 10 were ﬁtted with a biexponential
function given in Eqs. 1a and 1b, to describe the bimodal
proﬁle of LS intensity versus time for EAK16-II concen-
trations ranging from 0.08 mg/ml to 0.2 mg/ml:
0\t\t0;
IðtÞ
½EAK
0
¼ Kð1 ekf tÞ (1a)
t[t0;
IðtÞ
½EAK0
¼ K½1 eðkfksÞt0ekst: (1b)
The instant t0 (¼6 h) represents the time when the time
interval between two LS measurements was switched from
1 h to 24 h. At time t smaller than t0, the data were ﬁtted with
Eq. 1a, while Eq. 1b was used for the data at time t larger
than t0. The parameters kf and ks represent the rate constants
of aggregation at times smaller or larger than t0, respectively.
In Eqs. 1a and 1b, the LS intensity is normalized by the
peptide concentration to account for the trends shown in Fig.
10 where the ratio I(t)/[EAK]0 is found to be independent of
peptide concentration. The parameters in Eq. 1, a and b, were
optimized using the Marquardt-Levenberg algorithm (Press
et al., 1992). The ﬁt was good, indicating that Eqs. 1a and 1b,
represents the data satisfyingly. The rate constants kf and ks
were found to equal 0.0586 0.006 h1 and 0.00686 0.0004
h1, respectively.
The occurrence of the two different rate constants for the
aggregation of EAK16-II as shown in Fig. 9 A and Fig. 10
may be the result of the shear effect. The application of shear
or agitation has been reported to induce aggregation in blood
and latex solutions (Lougheed et al., 1980; Jen and Mclntire,
1984; Le Berre et al., 1998; Serra et al., 1997). It is because
agitating the solutions provides energy, which increases the
activity of molecules in a process of aggregation. Moreover,
shearing can also align long chain molecules such as
polymers, promoting their ability to interact with each other.
In each LS measurement, the sample was subject to shear on
two occasions, ﬁrst when it was pipetted out of the stock
solution into the cell and a second time during the reverse
process. Besides, the solutions were sheared more at the
beginning of the experiment (once per hour) than at the end
(once per day), which resulted in a rate of increase in
I(t)[EAK]0 10 times larger initially.
Our preliminary experiments about shear effect indicate
that the amount of shearing applied to the solutions affects
the LS intensity versus time proﬁles. This may explain why
the cutoff concentration, above which the LS intensity in-
creases signiﬁcantly with time, was found to be 0.08 gm/ml
in Fig. 9, C and D, and Fig. 10, not the CAC, which was de-
termined to be 0.1 mg/ml by surface tension experiments.
However, with the same amount of shear applied to all so-
lutions in this study, the concentration effect on the aggre-
gation process is still signiﬁcant (Fig. 9, B and C).
Induction time
When the concentration of peptide is sufﬁciently low, the
surface tension does not change within an initial time period,
which is referred to as the induction time. This phenomenon
exists in most biomolecular systems, and many mechanisms
have been proposed to explain it.Miller et al. (2001) proposed
a theory for the kinetics of globular protein adsorption based
on a diffusion model. In this theory, the induction time
represents the time required for the surface monolayer to
attain a certain minimum coverage, above which the surface
tension is reduced. Another group explained the existence of
an induction time by the phase change theory (Erickson et al.,
2000). The phase transition is a ﬁrst-order phase change from
a surface gaseous to a liquid-expanded state which occurs as
the proteins gradually adsorb at the surface. The surface
tension remains constant while the surface is in the gaseous
state, but decreases when the surface is in the liquid-expanded
state, yielding an induction period. Similarly, Ybert and di
Meglio (1998) hypothesized that during the induction time,
the protein is adsorbed in a surface gaseous state, so that the
surface pressure changes only slightly as the surface coverage
increases.
In earlier studies carried out with BSA solutions,
MacRitchie and Alexander (1963) proposed that the in-
546 Fung et al.
Biophysical Journal 85(1) 537–548
duction period represents a diffusion-controlled adsorption
time. This period ends when the interface is covered with
a certain number of proteins. This adsorbed protein mono-
layer creates an energy barrier for further adsorption. The
surface pressure increases only after this certain coverage is
reached. On the other hand, Van der Vegt et al. (1996)
proposed that the proteins do not change the surface pressure
until they have changed their conformations, and a mecha-
nism similar to that was suggested by Graham and Phillips
(1979).
Our surface tension experiments show that the induction
time decreases with the increase of EAK16-II concentration,
and the induction time disappears only at concentrations
above the CAC (Fig. 6). This could be explained by
considering both the diffusion-controlled mechanism and the
molecular self-rearrangement. For one molecule adsorbing
onto the surface, the molecule has to ﬁrst diffuse from the
bulk to the surface then rearrange itself at the surface, which
leads to the decrease of surface tension. Based on the
diffusion-controlled theory, the bulk concentration is the
main driving force for molecules to diffuse onto the surface.
Therefore, more EAK16-II molecules adsorb onto the
surface as the bulk concentration increases, resulting in an
inverse change relationship between the induction time and
the bulk concentration shown in Fig. 6. On the other hand,
EAK16-II monomers may rearrange themselves at the
surface via intermolecular interactions, which could lead to
the formation of b-sheet monolayers. This formation pro-
vides a better surface coverage, and hence changes the surface
tension signiﬁcantly. When the concentration is above the
CAC, EAK16-II monomers can ﬁrst self-organize to form
b-sheets in the bulk (nucleation process) then diffuse onto
the surface. This mechanism is opposed to the adsorption
of individual molecule onto the surface at concentrations
below the CAC. The adsorption of b-sheet monolayers could
reduce the time needed for further rearranging molecules
to obtain a better coverage of the surface, leading to an
immediate effect on the surface tension. This also implies
that the molecular self-association occurring in the bulk
facilitates the surface adsorption process.
CONCLUSIONS
An aggregation mechanism of a self-assembling oligopep-
tide, EAK16-II, has been proposed based on the results
obtained with three different experimental techniques.
EAK16-II molecules self-assemble into protoﬁbrils through
two pathways, namely seeding and nucleation, depending on
whether the concentration is below or above the CAC. The
CAC of EAK16-II has been found to be around 0.1 mg/ml.
Two nanostructures of protoﬁbrils, the globular aggregates
and the ﬁlaments, have been observed. Over time, these
protoﬁbrils further aggregate into ﬁbrils. The time-dependent
association process of EAK16-II was demonstrated by
monitoring the LS intensity of EAK16-II solutions as
a function of time. For concentrations above 0.08 mg/ml,
the LS intensity increases with time signiﬁcantly. This
increase is bimodal possibly due to a change in the amount of
shear applied to the sample.
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